Pre-operative Withdrawal of Aspirin in Laparoscopic Inguinal Hernia Repair
NCT ID: NCT02604732
Last Updated: 2023-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2016-04-01
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Evaluation of Pain After Non-complex Ventral Hernia Repair
NCT04855227
Ilioinguinal Block in Laparoscopic Inguinal Hernia Repair
NCT01969006
Laparoscopic Versus Robot-assisted Inguinal Hernia Repair: A Single Institution Randomized Controlled Trial
NCT03133533
Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias
NCT07289490
Pain and Quality of Life After Inguinal Hernia Repair
NCT04074200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients who stop Aspirin perioperatively
Patients undergoing laparoscopic inguinal hernia repair will stop Aspirin 5-7 days before the surgery
Laparoscopic inguinal hernia repair without perioperative Aspirin
Patients undergoing laparoscopic inguinal hernia repair will stop Aspirin 5-7 days before the surgery
Patients who continue Aspirin perioperatively
Patients undergoing laparoscopic inguinal hernia repair will continue on Aspirin perioperatively
Laparoscopic inguinal hernia repair with perioperative Aspirin
Patients undergoing laparoscopic inguinal hernia repair will continue on Aspirin perioperatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laparoscopic inguinal hernia repair with perioperative Aspirin
Patients undergoing laparoscopic inguinal hernia repair will continue on Aspirin perioperatively
Laparoscopic inguinal hernia repair without perioperative Aspirin
Patients undergoing laparoscopic inguinal hernia repair will stop Aspirin 5-7 days before the surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 21-80 years
* Patients taking Aspirin
* BMI 18-30
Exclusion Criteria
* Recurrent inguinal hernia
* Coagulopathy
* Patients who can't stop Aspirin
* BMI \<18 and \>30
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University Hospital, Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Davide Lomanto, MD PhD
Role: PRINCIPAL_INVESTIGATOR
National University Hospital, Singapore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National University Hospital
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Tan L, Yeow M, Fatt SLK, Parameswaran R, Mahipal M, Loo L, Wijerathne S, Lomanto D. Cessation vs no cessation of acetylsalicylic acid preoperatively in laparoscopic totally extraperitoneal inguinal hernia repair (CAPTAIN): final report from a multi-center, single-blinded, randomized-controlled trial. Hernia. 2025 Jul 5;29(1):221. doi: 10.1007/s10029-025-03418-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/00512
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.